Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
lung cancer treatment
Jun 5, 2024, 13:40 |
Immune Oncology
Immunotherapy for Ovarian Cancer: A Growing Field
How Immunotherapy Works for Ovarian Cancer Immunotherapy represents a paradigm shift in the treatment of…
Jun 5, 2024, 11:11 |
Societies
Rami Manochakian: ASCO24 is over but ASCO’s great mission in conquering cancer is ongoing
Rami Manochakian shared a post on X: “Incredible American Society of Clinical Oncology 2024 (ASCO24) is…
Jun 4, 2024, 09:15 |
Cancer Types
Oropharyngeal Cancer: What patients should know about
Oropharyngeal Cancer Oropharyngeal cancer is a type of head and neck cancer that affects the…
Jun 3, 2024, 22:53 |
Insight
Paul Healy: AstraZeneca and Daiichi Sankyo have announced positive results from datopotamab deruxtecan in certain lung cancer patients
Paul Healy, Director of PHARMeMED, shared on LinkedIn: "AstraZeneca (AZ) and Daiichi Sankyo have announced positive…
Jun 2, 2024, 22:20 |
Insight
Sylvester Cancer study on immunotherapy drug durvalumab shows limited access globally due to cost constraints
Access to Targeted Lung Cancer Drug Is Cost-Prohibitive Globally Many countries with national healthcare systems…
Jun 2, 2024, 13:01 |
Blog
Moffitt Cancer Center is the first healthcare provider in the US to commercially administer a newly-approved therapy for Small Cell Lung Cancer
Moffitt Cancer Center shared on their X/Twitter: ''Moffitt is the first healthcare provider in the…
Jun 2, 2024, 10:24 |
Blog
Lucy Jones: As childhood cancers are rare, the only way to drive research is with the support of the community
Lucy Jones, CEO at Neuroblastoma Australia, shared a post by Neuroblastoma Australia on LinkedIn, adding:…
Jun 1, 2024, 15:59 |
Immune Oncology
Immunotherapy for Lung Cancer
Lung cancer and immunotherapy Lung cancer is the leading cause of cancer-related deaths worldwide, with…
Jun 1, 2024, 14:40 |
Societies
Estela Rodriguez: Glad to be part of Sylvester Comprehensive Cancer Center's amazing group at ASCO24
Estela Rodriguez shared a post by Sylvester Comprehensive Cancer Center on LinkedIn, adding: "Glad to be part of…
Jun 1, 2024, 14:36 |
Blog
Albert Bourla: Results from our Phase 3 clinical trial evaluating treatments for patients with advanced ALK-positive NSCLC shared at ASCO24
Albert Bourla, Chairman and Chief Executive Officer of Pfizer, shared a post on LinkedIn: "We’re making…
23
24
25
26
27
All:
848
Posts:
241 - 250
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 6
ASTRO24: 15 Posts Not To Miss From Day 4
Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024
Paper Alert! Cutaneous Metastases in Thyroid Cancer: A Comprehensive Review of 136 Cases
ASTRO 24: 15 Posts Not to Miss From Day 3
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube